Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neuroendocrine Tumors 12Meningioma 5Prostatic Neoplasms 2Pheochromocytoma 2Paraganglioma 2Neuroblastoma 2Medulloblastoma 2Glioma 2Glioblastoma 2Ependymoma 2Carcinoma, Merkel Cell 2Sarcoma, Synovial 1Recurrence 1Pancreatic Neoplasms 1Osteosarcoma 1Neoplasms, Germ Cell and Embryonal 1Metastatic Digestive System Neuroendocrine Tumor G1 1Hypertension 1Gastro-enteropancreatic neuroendocrine tumor 1Extensive Stage Small Cell Lung Cancer 1Esthesioneuroblastoma, Olfactory 1Disease Progression 1Diffuse Intrinsic Pontine Glioma 1Central Nervous System Neoplasms 1Carcinoma 1Carcinoid Tumor 1Advanced Lung Neuroendocrine Tumor 1Adrenal Gland Neoplasms 1Adrenal Cortex Neoplasms 1Adenoma, Islet Cell 1

Interventions

Etoposide 3Carboplatin 3pembrolizumab 2fludarabine phosphate 2fludarabine 2Paclitaxel 2Cyclophosphamide 2Cisplatin 2repotrectinib 1pralsetinib 1lutetium Lu 177 dotatate 1Vorinostat 1Standard of Care 1Specimen Handling 1Respiratory Physiological Phenomena 1Practice Guidelines as Topic 1Platinum 1Pemetrexed 1Nivolumab 1Mesna 1Magnetic Resonance Spectroscopy 1Immunotherapy 1Ifosfamide 1Gemcitabine 1Cytapheresis 1Bleomycin 1Biopsy 1Automobiles 1130-nm albumin-bound paclitaxel 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Germ Cell and Embryonal × lutetium Lu 177 dotatate × 90 days × Clear all
NCT05278208 2026-04-13

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

Nationwide Children's Hospital

Phase 1/2 Recruiting
65 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Ependymoma, Glioma, Medulloblastoma, Meningioma, Neoplasms, Germ Cell and Embryonal, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡